Abstract:OBJECTIVE:To develop a HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and investigate its immunological features.METHODS:Thirty-two CB17SCID mice were randomly divided into 4 groups: group A (5 mice) subcutaneously injected with phosphate-buffered saline, group B (5 mice) intraperitoneally injected with human peripheral blood lymphocyte (PBL) for immune reconstruction, group C (11 mice) subcutaneously injected with human cervical carcinoma cell line SiHa, and group D (11 mice) intraperitoneally injected with PBL and subcutaneously injected with SiHa cells after 24 hours of PBL transplantation. The tumor growth, behaviors and status of xenogeneic graft versus host disease (XGVHD) were observed. Human immunoglobulins G (IgG) in mouse serum, the percentage of human CD3(+), CD4(+) and CD8(+) T cells in peripheral blood and spleen, spleen weight, tumor infiltrating lymphocytes and human CD4(+) T cells, and cytotoxicity test of spleen cells were detected.RESULTS:The rate of successful tumor transplantation was 100%. XGVHD was not found. On the 5th day, human IgG level in the group B (0.98 microg/ml +/- 0.20 microg/ml) and group D (1.39 microg/ml +/- 0.25 microg/ml) was significantly higher than that in the group A (t = 7.655, 9.937, both P = 0.000). Human IgG level in group D was significantly higher than that in the group B (t = 3.200, P = 0.006). Only very low levels of human serumal IgG were detected in the group C and group A with no significantly difference. The level of human serumal IgG was gradually elevated in all the humanized SCID mice as the the time after PBL transplantation went on, and was significantly higher than that in non-humanized mice (P < 0.05). The percentage of human CD3(+), CD4(+) and CD8(+) T cells was significantly increased in the peripheral blood and spleen of immunoreconstituted SCID mice. The weight of spleen was markedly increased in the group D. TIL infiltrating in the tumor were remarkable and human CD4(+) T cells was detected by immunohistochemistry in the group D but not in the group C. The spleen cells in the group D displayed stronger cytotoxicity to the target cells (P < 0.05).CONCLUSION:Human immune function can be successfully reconstructed in SCID mouse via intraperitoneally injecting with human PBL, and induce anti-tumor immune response to the transplantated tumor of HPV16 positive cervical cancer.

Study of Establish the Model for Human Papillomavirus 6,11 Infection

Establishment of Nude Mouse Model of Human Prostate Carcinoma by Subcutaneous Injection of Cell Line LNCaP

Establishment of a Cervical Cancer Model Via Inoculating SiHa Cells into Humanized Severe Combined Immunodeficient Mice.

The Study on Expression of Human Papillomavirus and Phosphotyrosione and Tyrosine Phosphatase 2 in Condyloma Acuminatum Tissue Remodeling

[Study on the Frequency of Human Papillomavirus Type 6 and Type 11 Infection and L1 Gene Expression of the Virus in Biopsy Samples of Pointed Condyloma Patients].

Preparation of Tissue-Engineered Skin Grafts with Htert Cells Carrying Human Papillomavirus Type 6 Genome in Vitro：a Preliminary Study

[Development of HPV16 Positive Cervical Cancer Model in the Hu-Pbl-scid Mouse and Its Immunological Features].

Advances of Cytokeratin Promoters in HPV Transgenic Mice

Advances in research on mouse models of papillomavirus infection

[Assay and L1 Gene Sequence Analysis of Human Papillomavirus Type 6 and 11 in Condylomata Acuminata].

Esablishment of Human Lung Cancer Model in the Scid Mouse

Establishment of human papillomavirus pseudovirion infection model in mouse for potency evaluation of HPV16 VLP Vaccine

Transgenic Mice Expressing Targeted Hpv-18-E6 And Hpv-18-E7 Oncogenes In The Epidermis Develop Verrucous Lesions And Spontaneous, Ras(Ha)-Activated Papillomas

A RESEARCH FOR THE RELATIONSHIP BETWEEN HUMAN PAPILLOMAVIRUS AND HUMAN UTERINE CERVICAL-CARCINOMA .2. MOLECULAR GENETIC AND ULTRASTRUCTURAL-STUDY ON THE TRANSFORMING ACTIVITY OF RECOMBINANT RETROVIRUS CONTAINING HUMAN PAPILLOMAVIRUS TYPE-16 SUBGENOMIC SEQUENCES

A Promising New Model: Establishment of Patient‐Derived Organoid Models Covering HPV‐Related Cervical Pre‐Cancerous Lesions and Their Cancers

Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7-Expressing Carcinoma in the Cervicovaginal Tract

Construction of Recombinant Plasmid of HPV16L1-E7C and the Primary Study of Its Cellular Immunity

Establishment of a Transplanted Tumor Model of Human Oral Squamous Cell Carcinoma in Nude Mice

[HPV Caused Pathological Changes in Genital System of Mice].

[Antitumor Immune Response to Cervix Carcinoma in Mice Induced by HPV16 E6 DNA Vaccines].

ESTABLISHMENT OF TRANSPLANTABLE AND ASCITES MODELS OF HUMAN OVARIAN CARCINOMA IN NUDE MICE AND THEIR MORPHOLOGICAL CHARACTERISTICS